Community 365 Roundtable on Early Detection and Screening

The Community 365 Roundtable Meeting on Early Detection and Screening took place on Tuesday 22 June 2021 from 15:30-17:30 CEST. 

This meeting brought together leading policy-makers, politicians, oncology experts and patient advocates to discuss the implementation of Europe’s Beating Cancer Plan and Cancer Mission.

22 June 2021 15:30 - 17:30 CEST

Virtual Meeting

Roundtable EarlyDetection June2021 1

 

This Roundtable focused on three areas and will be part of our development of an Advocacy Paper on this important topic:

  • Key scientific and technological developments in improving early detection for all cancers
  • Reviewing the experience of EU level initiatives on Breast and Colorectal cancer screening since 2003
  • The case for EU level initiatives to support lung cancer screening and early detection strategies for prostate cancer

 

Programme

15:30-16:05 Early Detection for All Cancers

This session will discuss key advances in the field of early detection of cancer through novel testing technologies. We will cover innovations with both tumour-specific and pan-tumour approaches.

Welcome and Introduction
  • Matti Aapro, President, European Cancer Organisation
  • Cindy Perettie, Head of Roche Molecular Lab
Keynote Presentations
  • Paul Limburg, Chief Medical Officer, Screening, at Exact Sciences on the rationale and application of multi-cancer early detection
  • Prof. Holger Moch, President, European Society of Pathology (ESP) on the early detection of treatment intervention targets in all cancers from the pathologist's perspective

Q&A Session

Including interventions from:

  • Natacha Bolaños, Global Alliances Manager and Regional Manager, Lymphoma Coalition Europe, and Member of the European Cancer Organisation’s Patient Advisory Committee, on the patient perspective and currently unmet needs in early detection of cancer
  • Rüdiger Greinert, Head of Dept. Mol. Cell Biology, Skin Cancer Center, Buxtehude, Germany; Secretary General of European Society of Skin Cancer Prevention (EUROSKIN) on early detection of skin cancer 
Conclusions
  • Matti Aapro, President, European Cancer Organisation
  • Cindy Perettie, Head of Roche Molecular Labs

 

16:05-16:35 EU Level Screening Initiatives: What Have we Learned so Far

This session will review the progress made since the 2003 EU Council Recommendations on Cancer Screening with examination of the case studies of Breast and Colorectal cancer. Lessons will be extracted for the future EU Cancer Screening Scheme envisaged as part of Europe’s Beating Cancer Plan.

Introduction
  • Isabel Rubio, President, European Society of Breast Cancer Specialists (EUSOMA); President-Elect European Society of Surgical Oncology (ESSO), Co-Chair of the European Cancer Organisation’s Prevention, Early Detection and Screening Network
Keynote Presentations
  • Harry de Koning, Professor of Public Health & Screening at Erasmus MC, Rotterdam on developments in breast cancer screening
  • Prof. Luigi Ricciardiello, Chair, Research Committee, United European Gastroenterology (UEG) on progress made on colorectal cancer screening
Highlights from the audience contributions

Including interventions from: 

  • Prof. Fiona Gilbert, President of European Society of Breast Imaging (EUSOBI)
  • Tanja Spanic, President of Europa Donna 
  • Zorana Maravic, Acting CEO of Digestive Cancers Europe (DiCE)
Conclusions
  • Isabel Rubio, President, European Society of Breast Cancer Specialists (EUSOMA); President-Elect European Society of Surgical Oncology (ESSO), Co-Chair of the European Cancer Organisation’s Prevention, Early Detection and Screening Network

 

16:35-17:10 The Development of New Screening and Tumour-specific Strategies

This session will investigate the potential for updating EU level screening and early detection recommendations with a focus on the examples of lung cancer and prostate cancer.

Introduction
  • Jan Van Meerbeeck, Co-Chair of Prevention, Early Detection and Screening Network, European Cancer Organisation
  • Karl Matussek, Head of Oncology Germany, AstraZeneca
Keynote Presentations
  • Emma O’Dowd, Consultant Respiratory Physician, Nottingham University Hospitals NHS Trust on the challenges in the implementation of lung cancer screening
  • Peter Albers, Professor & Chairman Of the Department Of Urology, Heinrich-Heine-University Düsseldorf & Board Member, European Association of Urology (EAU) on building the evidence for prostate cancer screening
Q&A Session

Including interventions from:

  • Marie-Pierre Revel, representing the European Society of Radiology (ESR) and Head of the Radiology Department, Cochin Hospital, University of Paris
  • Monique Roobol, representing the European Association of Urology (EAU) and Professor, Decision Making In Urology & Head of Scientific Research Office, Department of Urology at Erasmus Medical Centre, Rotterdam.
Conclusions
  • Jan Van Meerbeeck, Co-Chair of Prevention, Early Detection and Screening Network, European Cancer Organisation
  • Karl Matussek, Head of Oncology Germany, AstraZeneca

 

17:10-17:25 The Next Steps – Progressing the Agenda with the JRC and FEAM
  • Richard Price, EU Affairs Policy Manager at the European Cancer Organisation, will lead a conversation on the key opportunities presented by Europe’s Beating Cancer Plan and the EU Cancer Mission to achieve milestone improvement in screening and early detection.

Richard Price will be joined by:

  • Ciarán Nicholl, Head of the Health in Society Unit at the Joint Research Centre (JRC)
  • Prof. Stefan Constantinescu, President, Federation of European Academies of Medicine (FEAM), who are leading in the production of scientific advice for the EU Commission on this topic.

 

17:25-17:30 Closing Remarks
  • Isabel Rubio, President, European Society of Breast Cancer Specialists (EUSOMA); President-Elect European Society of Surgical Oncology (ESSO), Co-Chair of the European Cancer Organisation’s Prevention, Early Detection and Screening Network
  • Jan Van Meerbeeck, Co-Chair of the Prevention, Early Detection and Screening Network, European Cancer Organisation

Speakers

  • Peter Albers Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ)
  • Emma O'Dowd Consultant Respiratory Physician, Nottingham University Hospitals NHS Trust
  • Ciarán Nicholl Head of the Health in Society Unit, Joint Research Centre (JRC)
  • Paul Limburg Chief Medical Officer, Screening, Exact Sciences
  • Harry de Koning Professor, Public Health & Screening, Erasmus MC, Rotterdam
  • Holger Moch President, European Society of Pathology
show all speakers (21)

Speakers

  • Peter Albers Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ)
  • Emma O'Dowd Consultant Respiratory Physician, Nottingham University Hospitals NHS Trust
  • Ciarán Nicholl Head of the Health in Society Unit, Joint Research Centre (JRC)
  • Paul Limburg Chief Medical Officer, Screening, Exact Sciences
  • Harry de Koning Professor, Public Health & Screening, Erasmus MC, Rotterdam
  • Holger Moch President, European Society of Pathology
show all speakers (21)
  • Peter Albers Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ) Read Bio
  • Emma O'Dowd Consultant Respiratory Physician, Nottingham University Hospitals NHS Trust
  • Ciarán Nicholl Head of the Health in Society Unit, Joint Research Centre (JRC) Read Bio
  • Paul Limburg Chief Medical Officer, Screening, Exact Sciences Read Bio
  • Harry de Koning Professor, Public Health & Screening, Erasmus MC, Rotterdam
  • Holger Moch President, European Society of Pathology Read Bio
  • Luigi Ricciardiello Chair, Research Committee, United European Gastroenterology (UEG) Read Bio
  • Stefan Constantinescu President, Federation of European Academies of Medicine (FEAM)
  • Cindy Perettie Head of Roche Molecular Lab Read Bio
  • Karl Matussek Head of Oncology Germany, AstraZeneca Read Bio
  • Monique Roobol Professor, Decision Making in Urology and the Head of the scientific research office within the Department of Urology at Erasmus Medical Centre Rotterdam Read Bio
  • Marie Pierre Revel Head of the Radiology department, Cochin Hospital, University of Paris Read Bio
  • Natacha Bolaños Global Alliances Manager and Regional Manager, Lymphoma Coalition Europe, and Patient Advisory Committee Member, European Cancer Organisation Read Bio
  • Rüdiger Greinert Head of Dept. Mol. Cell Biology, Skin Cancer Center, Buxtehude, Germany; Secretary General of European Society of Skin Cancer Prevention (EUROSKIN)
  • Fiona Gilbert President, European Society of Breast Imaging (EUSOBI)
  • Tanja Spanic President, Europa Donna
  • Zorana Maravic Acting CEO, Digestive Cancers Europe (DiCE)
  • Matti Aapro President, European Cancer Organisation Read Bio
  • Jan Van Meerbeeck Prevention Network, Co-Chair, European Cancer Organisation Read Bio
  • Isabel Rubio President, European Society of Breast Cancer Specialists (EUSOMA), President-Elect, European Society of Surgical Oncology (ESSO), Prevention Network Co-Chair, European Cancer Organisation Read Bio
  • Richard Price EU Affairs Policy Manager, European Cancer Organisation

Speakers

  • Peter Albers Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ)
  • Emma O'Dowd Consultant Respiratory Physician, Nottingham University Hospitals NHS Trust
  • Ciarán Nicholl Head of the Health in Society Unit, Joint Research Centre (JRC)
  • Paul Limburg Chief Medical Officer, Screening, Exact Sciences
  • Harry de Koning Professor, Public Health & Screening, Erasmus MC, Rotterdam
  • Holger Moch President, European Society of Pathology
show all speakers (21)

Speakers

  • Peter Albers Professor of Urology, Düsseldorf University & Division Head, German Cancer Research Center (DKFZ)
  • Emma O'Dowd Consultant Respiratory Physician, Nottingham University Hospitals NHS Trust
  • Ciarán Nicholl Head of the Health in Society Unit, Joint Research Centre (JRC)
  • Paul Limburg Chief Medical Officer, Screening, Exact Sciences
  • Harry de Koning Professor, Public Health & Screening, Erasmus MC, Rotterdam
  • Holger Moch President, European Society of Pathology
show all speakers (21)